These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1066 related articles for article (PubMed ID: 9331085)

  • 21. Sialylation of intracellular proteins of thyroid lesions.
    Krzeslak A; Gaj Z; Pomorski L; Lipinska A
    Oncol Rep; 2007 May; 17(5):1237-42. PubMed ID: 17390071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloning, expression and gene organization of a human Neu5Ac alpha 2-3Gal beta 1-3GalNAc alpha 2,6-sialyltransferase: hST6GalNAcIV.
    Harduin-Lepers A; Stokes DC; Steelant WF; Samyn-Petit B; Krzewinski-Recchi MA; Vallejo-Ruiz V; Zanetta JP; Augé C; Delannoy P
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):37-48. PubMed ID: 11062056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation.
    Martin LT; Marth JD; Varki A; Varki NM
    J Biol Chem; 2002 Sep; 277(36):32930-8. PubMed ID: 12068010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a lectin binding assay to differentiate between recombinant and endogenous proteins in pharmacokinetic studies of protein-biopharmaceuticals.
    Weber A; Minibeck E; Scheiflinger F; Turecek PL
    J Pharm Biomed Anal; 2015 Apr; 108():21-8. PubMed ID: 25703236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic changes induced by expression of beta-galactoside alpha2,6 sialyltransferase I in the human colon cancer cell line SW948.
    Chiricolo M; Malagolini N; Bonfiglioli S; Dall'Olio F
    Glycobiology; 2006 Feb; 16(2):146-54. PubMed ID: 16192407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colon carcinoma glycoproteins carrying alpha 2,6-linked sialic acid reactive with Sambucus nigra agglutinin are not constitutively expressed in normal human colon mucosa and are distinct from sialyl-Tn antigen.
    Murayama T; Zuber C; Seelentag WK; Li WP; Kemmner W; Heitz PU; Roth J
    Int J Cancer; 1997 Mar; 70(5):575-81. PubMed ID: 9052758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour suppressor p16(INK4a) - anoikis-favouring decrease in N/O-glycan/cell surface sialylation by down-regulation of enzymes in sialic acid biosynthesis in tandem in a pancreatic carcinoma model.
    Amano M; Eriksson H; Manning JC; Detjen KM; André S; Nishimura S; Lehtiö J; Gabius HJ
    FEBS J; 2012 Nov; 279(21):4062-80. PubMed ID: 22943525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased alpha2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells.
    Jenner J; Kerst G; Handgretinger R; Müller I
    Exp Hematol; 2006 Sep; 34(9):1212-8. PubMed ID: 16939814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the specificity of sialyltransferases toward mucin core 2, globo, and related structures. identification of the sialylation sequence and the effects of sulfate, fucose, methyl, and fluoro substituents of the carbohydrate chain in the biosynthesis of selectin and siglec ligands, and novel sialylation by cloned alpha2,3(O)sialyltransferase.
    Chandrasekaran EV; Xue J; Xia J; Chawda R; Piskorz C; Locke RD; Neelamegham S; Matta KL
    Biochemistry; 2005 Nov; 44(47):15619-35. PubMed ID: 16300412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of hepatic neoplasms is severely retarded in mice lacking the bisecting N-acetylglucosamine on N-glycans: evidence for a glycoprotein factor that facilitates hepatic tumor progression.
    Bhaumik M; Harris T; Sundaram S; Johnson L; Guttenplan J; Rogler C; Stanley P
    Cancer Res; 1998 Jul; 58(13):2881-7. PubMed ID: 9661906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor suppressor p16INK4a--modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells.
    André S; Sanchez-Ruderisch H; Nakagawa H; Buchholz M; Kopitz J; Forberich P; Kemmner W; Böck C; Deguchi K; Detjen KM; Wiedenmann B; von Knebel Doeberitz M; Gress TM; Nishimura S; Rosewicz S; Gabius HJ
    FEBS J; 2007 Jul; 274(13):3233-56. PubMed ID: 17535296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas.
    Yamashita K; Taketa K; Nishi S; Fukushima K; Ohkura T
    Cancer Res; 1993 Jul; 53(13):2970-5. PubMed ID: 7686446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Precise mapping of increased sialylation pattern and the expression of acute phase proteins accompanying murine tumor progression in BALB/c mouse by integrated sera proteomics and glycomics.
    Lin SY; Chen YY; Fan YY; Lin CW; Chen ST; Wang AH; Khoo KH
    J Proteome Res; 2008 Aug; 7(8):3293-303. PubMed ID: 18549263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues.
    Raju TS; Briggs JB; Chamow SM; Winkler ME; Jones AJ
    Biochemistry; 2001 Jul; 40(30):8868-76. PubMed ID: 11467948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of serum, tumor, and liver serum glycoprotein: N-acetylneuraminic acid transferase activity with growth of the R3230AC mammary tumor in rats and relationship of the serum activity to tumor burden.
    Evans IM; Hilf R; Murphy M; Bosmann HB
    Cancer Res; 1980 Sep; 40(9):3103-11. PubMed ID: 7427928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rapid, semi-automated method for detection of Galbeta1-4GlcNAc alpha2,6-sialyltransferase (EC 2.4.99.1) activity using the lectin Sambucus nigra agglutinin.
    Halliday JA; Franks AH; Ramsdale TE; Martin R; Palant E
    Glycobiology; 2001 Jul; 11(7):557-64. PubMed ID: 11447135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic engineering of CHO cells producing human interferon-gamma by transfection of sialyltransferases.
    Fukuta K; Yokomatsu T; Abe R; Asanagi M; Makino T
    Glycoconj J; 2000 Dec; 17(12):895-904. PubMed ID: 11511814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice.
    Kenney NJ; Smith GH; Maroulakou IG; Green JH; Muller WJ; Callahan R; Salomon DS; Dickson RB
    Mol Carcinog; 1996 Jan; 15(1):44-56. PubMed ID: 8561865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis.
    Dall'Olio F; Chiricolo M; D'Errico A; Gruppioni E; Altimari A; Fiorentino M; Grigioni WF
    Glycobiology; 2004 Jan; 14(1):39-49. PubMed ID: 14514712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of α2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway.
    Yuan Q; Chen X; Han Y; Lei T; Wu Q; Yu X; Wang L; Fan Z; Wang S
    Int J Cancer; 2018 Nov; 143(9):2319-2330. PubMed ID: 29981167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.